Loading stock data…

Krystal Biotech Announces Orphan Drug Designation Granted to KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency

September 5, 2023 by Leave a Comment

Last Updated on September 5, 2023 by

[#item_full_content]

Related

Spread the word

You must log in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We provide a balanced view on small cap biotech equities

Address : Santa Fe, New Mexico.

Email : support@biotechwinners.com

© 2022 · Bio Tech Winners · Privacy Policy

Generated by Feedzy

%d bloggers like this: